{
  "docId": "019de075-881d-736b-8f07-b074ed7dfeb5",
  "docSlug": "6a57ccf571f205aca9c4c1050696b3ed",
  "documentTitle": "Enochian Biosciences | Results Presentation Deck | 43 slides",
  "authorId": "enochian-biosciences",
  "authorName": "Renovaro Biosciences",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-08-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 28,
  "pageCount": 43,
  "prevPage": 27,
  "nextPage": 29,
  "slideType": "solution",
  "function": "present_solution",
  "density": "dense",
  "nDataPoints": 0,
  "notes": null,
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de075-881d-736b-8f07-b074ed7dfeb5/28",
  "deckHref": "/decks/019de075-881d-736b-8f07-b074ed7dfeb5",
  "deckJsonHref": "/decks/019de075-881d-736b-8f07-b074ed7dfeb5.json",
  "deckAnchorHref": "/decks/019de075-881d-736b-8f07-b074ed7dfeb5#slide-28",
  "components": [
    {
      "bbox": {
        "h": 0.12,
        "w": 0.86,
        "x": 0.07,
        "y": 0.266
      },
      "kind": "list",
      "text": "GDT have been reported to be both a potential reservoir for, and effector T-Cells to kill, HIV-infected cells",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "35abc5ca-eafe-43ae-bb8b-38f16bc1b1ee",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.12,
        "w": 0.86,
        "x": 0.07,
        "y": 0.653
      },
      "kind": "list",
      "text": "Renovaro owns exclusive license",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "5366fed7-2c72-4143-93fc-82bab40de08b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.12,
        "w": 0.86,
        "x": 0.07,
        "y": 0.395
      },
      "kind": "list",
      "text": "Allogenicity is a potent immuno-stimulator",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c46bb675-5e45-41f0-93c1-50915fed9033",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.12,
        "w": 0.86,
        "x": 0.07,
        "y": 0.782
      },
      "kind": "list",
      "text": "Promising preliminary results from the subject without confounding factors",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c7580e90-6587-4b4e-906f-7b174548e93a",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.12,
        "w": 0.86,
        "x": 0.07,
        "y": 0.524
      },
      "kind": "list",
      "text": "Allogeneic GDT could be a potential therapy for HIV, in particular patients who cannot tolerate ART",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ce98d64e-cd9e-4be3-8511-562b5749510f",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.12,
        "w": 0.88,
        "x": 0.06,
        "y": 0.08
      },
      "kind": "title",
      "text": "RENB-HV-21: ALLOGENEIC NK PLUS GAMMA DELTA T (GDT) CELLS AS POTENTIAL THERAPY FOR HIV",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "6de97e49-ea96-4200-a00d-cb95bfd454ba",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 41,
      "from": 20,
      "beatId": "6eecc098-6bf4-4899-a6b6-ab99a8058bdc",
      "arcName": "Problem-Agitate-Solution",
      "arcSlug": "problem-agitate-solution",
      "beatName": "Impact & Next Steps",
      "beatSlug": "consultants-gambit-impact-next-steps",
      "evidence": "Slides 20-41 outline the current status and potential near-term milestones for multiple programs, as well as the company's intellectual property and future plans.",
      "position": 2,
      "confidence": 0.8,
      "parentBeatName": "Resolution",
      "parentBeatSlug": "resolution"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}